Paris: Life Sciences and Health Care Horizons 2019

You're Invited: Annual Paris Life Sciences Seminar and Arrival Cocktail for Charlotte Damiano 

Sydney: Join leaders from Hogan Lovells Medical Device team for conversation and cocktails

We welcome you to join members of our medical device and health care regulatory team as we discuss how to navigate the shifting regulatory landscape facing medical device firms. From...

London: Life Sciences and Health Care Horizons 2019

We are excited to announce our speakers at this year's Hogan Lovells Life Sciences Summit.

Boston: Life Sciences and Health Care Horizons 2019

The fast pace of innovation in the life sciences and health care industry is quickly transforming the health and vitality of the world we live in. It can be a challenge to keep up, let...

ACI's FDA Boot Camp (New York)

Scott Kaplan presented on the topic "Understanding FDA Enforcement and Authority and Actions" at the 33rd American Conference Institute's (ACI) FDA Boot Camp in New York.

The impact of Brexit on the pharmaceutical and medical device industries

Our European Life Sciences Regulatory team has been examining the potential consequences of Brexit for the pharmaceutical and medical device industries since before the results of the...

CBD and the changing regulatory landscape for hemp-derived products

Please join us on Tuesday, February 26 for a webinar on the regulatory landscape for hemp-derived products, including cannabidiol, or CBD.

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

Loading data